Immunotech Laboratories Inc (IMMB)

[trader53]

IMMB "temporary" suspension of trading

IMMB - Targets 0.02 / 0.03
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108049403


http://www.otcmarkets.com/stock/IMMB/news/SEC-Suspension-of-Trading?id=92127&b=y

SEC Suspension of Trading
Nov 20, 2014
OTC Disclosure & News Service

Washington, D.C. -

U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.


SECURITIES EXCHANGE ACT OF 1934
Release No. 73650 / November 20, 2014


The U.S. Securities and Exchange Commission
announced the temporary suspension of trading
pursuant to Section 12(k)
of the Securities Exchange Act of 1934
(the “Exchange Act”)
in the securities of the following issuers,
commencing at 9:30 a.m. EST
on November 20, 2014, and
terminating at 11:59 p.m. EST
on December 4, 2014:


• Bravo Enterprises Ltd. (OGNG)
• Immunotech Laboratories, Inc. (IMMB)
• Myriad Interactive Media, Inc. (MYRY)
• Wholehealth Products, Inc. (GWPC)


The Commission temporarily suspended trading
in the securities of the foregoing companies due
to questions that have arisen concerning the
accuracy and adequacy of publicly disseminated
information, including information about the
relationship between the companies’ business
prospects and the current Ebola crisis.


The Commission acknowledges the assistance
of FINRA in this matter.


The Commission cautions brokers, dealers,
shareholders and prospective purchasers that they
should carefully consider the foregoing information
along with all other currently available
information and any information subsequently
issued by these companies.
Further, brokers and dealers should be alert
to the fact that, pursuant to Rule 15c2-11
under the Exchange Act, at the termination
of the trading suspensions, no quotations may
be entered unless and until they have strictly
complied with all of the provisions of the
rule. If any broker or dealer has any questions
as to whether or not he has complied with
the rule, he should not enter any quotation
but immediately contact the staff in the
Division of Trading and Markets, Office of
Interpretation and Guidance, at (202) 551-
5777. If any broker or dealer is uncertain
as to what is required by Rule 15c2-11, he
should refrain from entering quotations
relating to the securities until such time as
he has familiarized himself with the rule
and is certain that all of its provisions have been
met. If any broker or dealer enters any
quotation that is in violation of the rule, the
Commission will consider the need for prompt
enforcement action.


If any broker, dealer or other person
has any information that may relate to this matter,
they should immediately contact Amy Gwiazda,
Assistant Regional Director,
Boston Regional Office at [phone],
or Robert Conrrad, Assistant Regional Director, Los
Angeles Regional Office at [phone].

Copyright © 2014 OTC Markets. All Rights Reserved